Vulnerabilities

Vulnerability · CVE-2026-103902

Improper verification of cryptographic signature vulnerability in DigiDoc libdigidocpp, DigiDoc DigiDoc4, DigiDoc DigiDoc Android, and DigiDoc DigiDoc iOS.

Published Oct 12, 2026 · catalog updated Oct 15, 2026 · Improper verification of cryptographic

Check if you run it

No confirmed exploitation is on record for CVE-2026-103902. EPSS is 0.15%. Act only if a listed version of Improper verification of cryptographic is installed.

Gaps on this record

  • The stored product name is a package slug. The name on this page is taken from the title (Improper verification of cryptographic).
  • No version range is stored. A customer cannot check an installed version against this record.
  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High7.5
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.15%
Remediation
Not established
Affected products
See sources for product scope

Improper verification of cryptographic signature vulnerability in DigiDoc libdigidocpp, DigiDoc DigiDoc4, DigiDoc DigiDoc Android, and DigiDoc DigiDoc iOS. The vulnerability allows an attacker to create forged digital signatures that are displayed a valid by affected DigiDoc software.This issue affects libdigidocpp: from 4.0.0 before 4.5.0; DigiDoc4: from 4.6.0 before 4.11.0; DigiDoc Android: from 2.7.0 before 3.1.0; DigiDoc iOS: from 2.7.0 before 3.1.0.

No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.

How to fix CVE-2026-103902

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2026-103902. EPSS is 0.15%. Act only if a listed version of Improper verification of cryptographic is installed.

Which versions are affected?

Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-347: Improper Verification of Cryptographic Signature. EPSS 0.15%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Oct 12, 2026 · NIST NVD

    Detected

    Improper verification of cryptographic signature vulnerability in DigiDoc libdigidocpp, DigiDoc DigiDoc4, DigiDoc DigiDoc Android, and DigiDoc DigiDoc iOS. The vulnerability allows an attacker to create forged digital signatures that are displayed a valid by affected DigiDoc software.This issue affects libdigidocpp: from 4.0.0 before 4.5.0; DigiDoc4: from 4.6.0 before 4.11.0; DigiDoc Android: from

  2. Oct 15, 2026 · NIST NVD

    Updated

    Improper verification of cryptographic signature vulnerability in DigiDoc libdigidocpp, DigiDoc DigiDoc4, DigiDoc DigiDoc Android, and DigiDoc DigiDoc iOS. The vulnerability allows an attacker to create forged digital signatures that are displayed a valid by affected DigiDoc software.This issue affects libdigidocpp: from 4.0.0 before 4.5.0; DigiDoc4: from 4.6.0 before 4.11.0; DigiDoc Android: from

Sources

  • CVE.orgVulnerability recordCVE-2026-103902

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2026-103902

    30-day exploitation probability 0.1%

    first.org
  • NIST NVDVulnerability recordCVE-2026-103902

    Improper verification of cryptographic signature vulnerability in DigiDoc libdigidocpp, DigiDoc DigiDoc4, DigiDoc DigiDoc Android, and DigiDoc DigiDoc iOS. The vulnerability allows an attacker to create forged digital signatures that are displayed a valid by affected DigiDoc sof

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.